Roche Holding AG (RHHBF OTCQX) stock market data APIs
$369.5706
5.37(1.5%)
as of October 20, 2025
Try our APIs with
free plan!
Roche Holding AG Financial Data Overview
Price chart is built with
Anychart
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. The company was founded in 1896 and is based in Basel, Switzerland.
Prev. Close
369.5706
Open
374.9398
High
374.9398
Low
369.5706
52 wk Range
272.0136-395.28
Market Cap
286 925 M
P/E Ratio
25.258
Shares Outstanding
107 M
Revenue
63 488 M
EPS
4.8905
Dividends (Yield)
0.0261
Beta
0.179
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Roche Holding AG (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Roche Holding AG data using free add-ons & libraries
Get Roche Holding AG Fundamental Data
Roche Holding AG Fundamental data includes:
- Net Revenue: 63 488 M
- EBITDA: 23 429 M
- Earnings Per Share: 14
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-04-21
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Roche Holding AG News
New
AstraZeneca's Cancer Breakthrough: Enhertu Data Sparks New Hope for Early Breast Cancer Cure
This article first appeared on GuruFocus. AstraZeneca (NASDAQ:AZN) and Daiichi Sankyo just delivered one of the most consequential oncology updates of the year. Their breast cancer therapy, Enhertu, ...
Top 1% Celcuity Stock Shoots To Record High On Roche-Rivaling Breast Cancer Results
Celcuity stock shot to a record high Monday after the company said its experimental drug delayed breast cancer progression for over a year. Continue Reading View comments
Olema Pharmaceuticals Shares Fall After Roche's Breast Cancer Data Weighs on Sector
Olema Pharmaceuticals (OLMA) shares fell 14% in Monday trading even after encouraging results for it PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscri...
IMPALA Appoints Ann Marie Dunne as New Chair, Succeeding Jonathan Taylor
IMPALA PISCATAWAY, N.J., Oct. 20, 2025 (GLOBE NEWSWIRE) -- IMPALA, a global consortium dedicated to advancing digital and analytics-driven quality in biopharmaceutical development, announced the appo...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
